Vical Announces Webcast of CEO Presentation at BIO InvestorForum
10/18/2005 4:05:50 PM
SAN DIEGO, Oct 18, 2005 /PRNewswire-FirstCall via COMTEX/ -- Vical Incorporated (VICL) today announced that its presentation at the BIO InvestorForum will be webcast live on Wednesday, October 19, 2005, at 3:20 p.m. Pacific Time. Vical's President and Chief Executive Officer, Vijay B. Samant, will provide an overview of the company's technologies, development programs, and strategic partnerships. The audio and slide show webcast will be available through a link in the Webcast Center at www.vical.com. A replay will be available.
About Vical
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company has retained all rights to its internally developed product candidates. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and serve significant unmet medical needs. Additional information on Vical is available at www.vical.com. |
